Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Corticosteroid-sparing
100%
Retention Time
100%
Immunomodulatory Drugs (IMiDs)
100%
Inflammatory Eye Disease
100%
Methotrexate
83%
Cyclophosphamide
50%
Mycophenolate Mofetil
50%
Ciclosporin
50%
Treatment Duration
33%
Steroid-sparing
33%
Clinical Data
16%
Medical Records
16%
Uveitis
16%
Study Support
16%
Remission
16%
Adverse Events
16%
Tolerability
16%
Drug Effectiveness
16%
Tertiary Referral
16%
Age Data
16%
Immunosuppressive Drugs
16%
Systemic Immunosuppression
16%
Corticosteroids
16%
Cox Regression Analysis
16%
Systemic Steroids
16%
Drug Tolerability
16%
Ocular Diagnoses
16%
Medicine and Dentistry
Eye Disease
100%
Immunosuppressive Drug
100%
Corticosteroid
100%
Methotrexate
83%
Azathioprine
50%
Cyclosporine
50%
Cyclophosphamide
50%
Mycophenolate Mofetil
50%
Treatment Duration
33%
Steroid
33%
Health Care Cost
16%
Immunosuppressive Treatment
16%
Uveitis
16%
Patient Referral
16%
Clinical Study
16%
Proportional Hazards Model
16%
Drug Efficacy
16%
Drug Tolerability
16%
fertility
16%
Regression Analysis
16%
Adverse Event
16%
Pharmacology, Toxicology and Pharmaceutical Science
Eye Disease
100%
Immunosuppressive Agent
100%
Corticosteroid
100%
Methotrexate
83%
Azathioprine
50%
Ciclosporin
50%
Cyclophosphamide
50%
Mycophenolate Mofetil
50%
Tolerability
33%
Steroids
33%
Clinical Study
16%
Adverse Event
16%
Remission
16%
Uveitis
16%
Oxymetazoline
16%
Neuroscience
Ophthalmic Disorder
100%
Immunosuppressive Drug
100%
Corticosteroid
100%
Methotrexate
83%
Ciclosporin
50%
Cyclophosphamide
50%
Azathioprine
50%
Mycophenolate Mofetil
50%
Steroids
33%
Immunosuppression
16%
Uveitis
16%
Regression Analysis
16%